相关实验视频

Updated: Jun 12, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

用机器学习和生存分析优化肝癌的预后预测

Kaida Cai^1,2,3, Wenzhi Fu², Zhengyan Wang²

¹Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China.

Entropy (Basel, Switzerland)

|September 27, 2024

概括

这项研究使用先进的数据分析确定了肝癌进展的关键遗传标记. 这些发现改善了对肝肝细胞癌 (LIHC) 结果的预测,并支持个性化癌症治疗.

科学领域:

基因组学就是基因组学.
在瘤学瘤学.
生物信息学是一种生物信息学.

背景情况:

肝肝细胞癌 (LIHC) 是一个重要的全球健康问题,预后不佳,治疗选择有限.
识别可靠的遗传标记对于理解LIHC进展和开发向治疗至关重要.

研究的目的:

使用RNA测序数据识别与LIHC进展相关的关键遗传标记.
评估各种特征选择和生存分析方法的性能,以预测LIHC结果.

主要方法:

为了LIHC,利用了来自癌症基因组图谱 (TCGA) 的RNA测序数据.
采用的特征选择技术:使用最小绝对收缩和选择运算符 (Lasso) 的确定独立选 (SIS),平滑切割绝对偏差 (SCAD),信息获取 (IG) 和变换变量重要性 (VIMP).
应用生存分析模型:Cox比例危险模型,生存树和随机生存森林.

主要成果:

确定了MED8作为LIHC的关键基因标记物.
SIS-Lasso与考克斯的比例危险模型相结合,显示出强大的预测准确度.
随机生存森林的SIS-VIMP方法在预测LIHC结果方面取得了最高的整体表现.

结论:

先进的特征选择和生存分析方法有效地识别LIHC的遗传标记.
随机生存森林的SIS-VIMP方法为LIHC提供了卓越的预测能力.
研究结果提供了LIHC遗传基础的见解,有助于个性化医学和癌症基因组学研究.

关键词:

功能选择功能选择获取信息获取信息肝脏肝细胞癌是肝脏细胞癌.机器学习是机器学习.生存分析,生存分析.

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...